Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial introductions69
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies47
Research frontiers in urology45
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis43
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects25
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology23
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma21
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments21
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update19
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker18
The role of innovations in advancing urologic oncologic patient care18
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
Editorial introductions17
RNA-based urinary assays for non-muscle invasive bladder cancer16
Editorial introductions16
Editorial introductions15
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer15
Testicular cancer with small metastatic burden: optimal approach in 202415
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations14
Sustainable practices in hospital and operating theaters13
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma13
Tissue-based gene expression testing in localized prostate cancer12
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature11
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions11
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?11
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging11
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature11
Optimizing clinical risk stratification of localized prostate cancer11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints9
Update on classification of oncocytic neoplasms of the kidney9
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology9
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects9
Is there a role for metastasis-directed therapy in bladder cancer?9
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors9
Brief update of the new WHO classification for urothelial carcinoma8
Metabolic syndrome, obesity and cancer risk8
Preoperative geriatric assessment of urological patients: a narrative review8
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities8
Histologic subtypes of urothelial carcinoma: an update8
Management of vaginoplasty canal complications8
Patient-reported outcomes in genital gender-affirming surgery7
The role of surgery for locally advanced urothelial cancers7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
Preoperative patient optimization for endourological procedures: the current best clinical practice7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer7
Toxicities of taxane-based chemotherapy in prostate cancer7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Decoding germ cell tumours for clinicians7
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer6
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes6
Medical therapy for male infertility6
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma6
Advanced sperm tests and impact on clinical male factor management6
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology6
Percutaneous management of caliceal diverticula: a narrative review6
Editorial introductions6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
AI-powered radiomics: revolutionizing detection of urologic malignancies6
Implications and effects of COVID-19 on diagnosis and management of prostate cancer6
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature6
MR-guided radiotherapy for prostate cancer: an inevitable transition?6
Liquid biomarkers in prostate cancer: recent advancements and future directions6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis6
Use of genomic markers to improve epidemiologic and clinical research in urology5
Genetics of testicular cancer: a review5
Metabolic evaluation: is there really a future?5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy5
Inflammation and kidney stones: cause and effect?5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era5
Editorial introductions5
Overlooked and underserved: how healthcare fails men in the pursuit of equity5
The carbon footprint of modern imaging5
Surgical management of testicular cancer with limited retroperitoneal disease5
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis5
The environmental impacts of anesthesia5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses5
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review4
Bladder diverticula management – conservative and surgical outcomes: a narrative review from EAU endourology4
Preclinical models for bladder cancer therapy research4
Pelvic pain syndromes4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis4
Artificial intelligence in endourology: emerging technology for individualized care4
Endo-technology and its future: where are we heading?4
Medical management of male infertility: now and future4
How to present quality of life outcomes after focal therapy: using validated instruments and novel statistical methods4
New technologies for nephron-sparing surgery in upper urinary tract cancers4
The use of MRI in urothelial carcinoma4
Urachal cancer: a clinical, diagnostic, and therapeutic update4
Organ storage in renal transplantation4
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?4
Role of cytoreductive surgery in the era of immunotherapy4
Transperineal vs. transrectal biopsy to reduce postinterventional sepsis4
Nectin-4 in bladder cancer: biology and predictive biomarker potential4
Small tools, big impact and redefining endourology: the paradigm shift of ureteroscopy for large stones and percutaneous nephrolithotomy for small stones – a literature review4
Advances in ureteral stent technology4
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters4
Novel intravesical delivery systems for nonmuscle invasive bladder cancer4
Editorial: Future of kidney stone management4
Leveraging behavioral modification technology for the prevention of kidney stones4
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population4
Editorial introductions4
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers4
Editorial introductions4
Editorial introductions4
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherap4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models4
Integration of novel artificial intelligence tools in pediatric urologic practice4
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis4
Editorial introductions4
0.097586870193481